The Medicines Advice Service Evaluation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

677 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-11-30

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find out whether talking to a pharmacist on the telephone can help to support people taking medicine for a long-term condition.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy

NCT02026453

Adverse Drug Events

COMPLETED NA

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

NCT00916214

Polypharmacy

COMPLETED PHASE2

Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients

NCT00122122

Geriatrics Drug Therapy Poly Pharmacy

COMPLETED PHASE3

The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients

NCT00122421

Diabetes Mellitus

COMPLETED NA

Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults

NCT03156348

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Non-adherence to medication is common and although some interventions have shown promise in improving adherence, the findings are inconsistent. This randomised controlled trial aims to test the effectiveness of a pharmacy-based telephone intervention compared to usual care on medication adherence and health outcomes in patients taking medicines for a long-term condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Hyperlipidemias

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient-centred tailored intervention

Medicines Advice Service

Group Type EXPERIMENTAL

Medicines Advice Service

Intervention Type OTHER

The intervention consists of:

1. Telephone consultations with a pharmacist
2. Follow-up tailored written information
3. A medicine reminder chart

Control

Usual care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medicines Advice Service

The intervention consists of:

1. Telephone consultations with a pharmacist
2. Follow-up tailored written information
3. A medicine reminder chart

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients prescribed medication(s) for at least one of the following conditions: type 2 diabetes, hyperlipidemia

Exclusion Criteria

* Patients living outside of England
* Patients with no access to a telephone
* Patients under the age of 18
* Patients unable to give written informed consent
* Patients on drugs for dementia
* Patients showing signs of dementia or cognitive impairment in conversation
* Patients with substantial hearing or sight impairment
* Patients whose medications are ordered by a caregiver/family member
* Patients with insufficient English to take part in the telephone intervention
* Patients living with someone already taking part in the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No